Annual Current Liabilities
$3.72 M
+$2000.00+0.05%
March 31, 2024
Summary
- As of February 7, 2025, SNOA annual total current liabilities is $3.72 million, with the most recent change of +$2000.00 (+0.05%) on March 31, 2024.
- During the last 3 years, SNOA annual current liabilities has fallen by -$359.00 thousand (-8.80%).
- SNOA annual current liabilities is now -62.94% below its all-time high of $10.03 million, reached on March 31, 2007.
Performance
SNOA Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$3.70 M
+$394.00 K+11.91%
December 31, 2024
Summary
- As of February 7, 2025, SNOA quarterly total current liabilities is $3.70 million, with the most recent change of +$394.00 thousand (+11.91%) on December 31, 2024.
- Over the past year, SNOA quarterly current liabilities has increased by +$629.00 thousand (+20.46%).
- SNOA quarterly current liabilities is now -63.10% below its all-time high of $10.03 million, reached on March 31, 2007.
Performance
SNOA Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
SNOA Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +0.1% | +20.5% |
| 3 y3 years | -8.8% | -0.4% |
| 5 y5 years | +3.6% | -0.4% |
SNOA Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -36.1% | +0.1% | -36.4% | +20.5% |
| 5 y | 5-year | -36.1% | +3.6% | -36.4% | +20.5% |
| alltime | all time | -62.9% | +44.1% | -63.1% | +77.7% |
Sonoma Pharmaceuticals Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | - | $3.70 M(+11.9%) |
| Sep 2024 | - | $3.31 M(-11.8%) |
| Jun 2024 | - | $3.75 M(+0.9%) |
| Mar 2024 | $3.72 M(+0.1%) | $3.72 M(+21.0%) |
| Dec 2023 | - | $3.07 M(-5.1%) |
| Sep 2023 | - | $3.24 M(-19.8%) |
| Jun 2023 | - | $4.04 M(+8.7%) |
| Mar 2023 | $3.72 M(-36.1%) | $3.72 M(-5.5%) |
| Dec 2022 | - | $3.93 M(+11.5%) |
| Sep 2022 | - | $3.53 M(-27.3%) |
| Jun 2022 | - | $4.85 M(-16.6%) |
| Mar 2022 | $5.82 M(+42.7%) | $5.82 M(+50.2%) |
| Dec 2021 | - | $3.88 M(-5.0%) |
| Sep 2021 | - | $4.08 M(-22.1%) |
| Jun 2021 | - | $5.23 M(+28.3%) |
| Mar 2021 | $4.08 M(-13.8%) | $4.08 M(+5.0%) |
| Dec 2020 | - | $3.88 M(-15.0%) |
| Sep 2020 | - | $4.57 M(-16.5%) |
| Jun 2020 | - | $5.47 M(+15.7%) |
| Mar 2020 | $4.73 M(+31.7%) | $4.73 M(+13.7%) |
| Dec 2019 | - | $4.16 M(-11.3%) |
| Sep 2019 | - | $4.69 M(+13.3%) |
| Jun 2019 | - | $4.13 M(+15.1%) |
| Mar 2019 | $3.59 M(+10.1%) | $3.59 M(+8.0%) |
| Dec 2018 | - | $3.33 M(+8.1%) |
| Sep 2018 | - | $3.08 M(-11.6%) |
| Jun 2018 | - | $3.48 M(+6.8%) |
| Mar 2018 | $3.26 M(-0.8%) | $3.26 M(-3.9%) |
| Dec 2017 | - | $3.39 M(+5.8%) |
| Sep 2017 | - | $3.21 M(+7.5%) |
| Jun 2017 | - | $2.98 M(-9.3%) |
| Mar 2017 | $3.29 M(-7.4%) | $3.29 M(-12.4%) |
| Dec 2016 | - | $3.75 M(+19.1%) |
| Sep 2016 | - | $3.15 M(-10.8%) |
| Jun 2016 | - | $3.53 M(-0.5%) |
| Mar 2016 | $3.55 M | $3.55 M(+27.1%) |
| Dec 2015 | - | $2.79 M(+8.6%) |
| Sep 2015 | - | $2.57 M(-5.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2015 | - | $2.73 M(+5.8%) |
| Mar 2015 | $2.58 M(-65.9%) | $2.58 M(-26.7%) |
| Dec 2014 | - | $3.52 M(-21.1%) |
| Sep 2014 | - | $4.46 M(-21.6%) |
| Jun 2014 | - | $5.69 M(-24.9%) |
| Mar 2014 | $7.57 M(+47.7%) | $7.57 M(+53.9%) |
| Dec 2013 | - | $4.92 M(+3.9%) |
| Sep 2013 | - | $4.74 M(-0.5%) |
| Jun 2013 | - | $4.76 M(-7.2%) |
| Mar 2013 | $5.13 M(+8.0%) | $5.13 M(-3.2%) |
| Dec 2012 | - | $5.30 M(-28.9%) |
| Sep 2012 | - | $7.45 M(+28.8%) |
| Jun 2012 | - | $5.78 M(+21.8%) |
| Mar 2012 | $4.75 M(+7.6%) | $4.75 M(+8.2%) |
| Dec 2011 | - | $4.39 M(+4.3%) |
| Sep 2011 | - | $4.21 M(-13.7%) |
| Jun 2011 | - | $4.88 M(+10.4%) |
| Mar 2011 | $4.42 M(+61.4%) | $4.42 M(+51.3%) |
| Dec 2010 | - | $2.92 M(+18.5%) |
| Sep 2010 | - | $2.46 M(-4.8%) |
| Jun 2010 | - | $2.59 M(-5.3%) |
| Mar 2010 | $2.73 M(+2.1%) | $2.73 M(+31.2%) |
| Dec 2009 | - | $2.08 M(-6.0%) |
| Sep 2009 | - | $2.22 M(-24.5%) |
| Jun 2009 | - | $2.94 M(+9.7%) |
| Mar 2009 | $2.68 M(-64.0%) | $2.68 M(-21.9%) |
| Dec 2008 | - | $3.43 M(-16.3%) |
| Sep 2008 | - | $4.10 M(-14.2%) |
| Jun 2008 | - | $4.78 M(-35.9%) |
| Mar 2008 | $7.45 M(-25.8%) | $7.45 M(+38.8%) |
| Dec 2007 | - | $5.37 M(+5.7%) |
| Sep 2007 | - | $5.08 M(-43.2%) |
| Jun 2007 | - | $8.94 M(-11.0%) |
| Mar 2007 | $10.03 M(+96.7%) | $10.03 M(+7.0%) |
| Dec 2006 | - | $9.38 M(+50.5%) |
| Sep 2006 | - | $6.23 M(+22.2%) |
| Mar 2006 | $5.10 M(+20.9%) | $5.10 M(+20.9%) |
| Mar 2005 | $4.22 M | $4.22 M |
FAQ
- What is Sonoma Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for Sonoma Pharmaceuticals?
- What is Sonoma Pharmaceuticals annual current liabilities year-on-year change?
- What is Sonoma Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Sonoma Pharmaceuticals?
- What is Sonoma Pharmaceuticals quarterly current liabilities year-on-year change?
What is Sonoma Pharmaceuticals annual total current liabilities?
The current annual current liabilities of SNOA is $3.72 M
What is the all time high annual current liabilities for Sonoma Pharmaceuticals?
Sonoma Pharmaceuticals all-time high annual total current liabilities is $10.03 M
What is Sonoma Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, SNOA annual total current liabilities has changed by +$2000.00 (+0.05%)
What is Sonoma Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of SNOA is $3.70 M
What is the all time high quarterly current liabilities for Sonoma Pharmaceuticals?
Sonoma Pharmaceuticals all-time high quarterly total current liabilities is $10.03 M
What is Sonoma Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, SNOA quarterly total current liabilities has changed by +$629.00 K (+20.46%)